Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like HUL wins ice cream ad lawsuit against Amul in Bombay high court June 16, 2017 Manufacturing Without Compromise April 13, 2018 Does Automotive Wheel Machining Benefit From a Purpose-Built Wheel Machine? October 27, 2017